Nutex Health Inc. Common Stock (NUTX) is a publicly traded Healthcare sector company. As of July 21, 2026, NUTX trades at $168.21 with a market cap of $1.11B and a P/E ratio of 15.07. NUTX moved +5.28% today. Year to date, NUTX is -11.39%; over the trailing twelve months it is +41.88%. Its 52-week range spans $28.12 to $204.00. Analyst consensus is strong buy with an average price target of $233.33. Rallies surfaces NUTX's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks politician and congressional stock disclosures for NUTX, including purchases, sales, transaction dates, owners, and reported trade amounts when available.
| Metric | Value |
|---|---|
| Price | $168.21 |
| Market Cap | $1.11B |
| P/E Ratio | 15.07 |
| EPS | $11.13 |
| Dividend Yield | 0.00% |
| 52-Week High | $204.00 |
| 52-Week Low | $28.12 |
| Volume | 103.44K |
| Avg Volume | 0 |
| Revenue (TTM) | $875.26M |
| Net Income | $180.36M |
| Gross Margin | 50.76% |
3 analysts cover NUTX: 0 strong buy, 3 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $233.33.